To cite this paper use one of the standards below:
The emergence of multidrug-resistant strains of Candida albicans, together with reduced efficacy of conventional antifungal drugs, has reinforced its status as a clinically important fungal pathogen and highlights the need for new therapeutic strategies. Photodynamic inactivation (PDI) has emerged as a promising antimicrobial approach, in which light-activated photosensitizers (PSs) generate reactive oxygen species (ROS), leading to microbial death via oxidative stress. Cationic Zn(II) porphyrins (ZnPs) have been gaining attention as potential PSs for PDI. In particular, ZnTnHex-2-PyP4+ (ZnP-hexyl) exhibits a high capacity for ROS production and cellular interaction. Therefore, this study aimed to investigate the ZnP-hexyl-mediated PDI of multidrug-resistant (MDR) C. albicans. The MDR strains HGV 23.1, HGV 51, and HGV 53.2 were obtained from the URM Mycology Laboratory Culture Collection at the Federal University of Pernambuco. HGV 23.1 is resistant to voriconazole (VOR) and fluconazole (FLU); HGV 51 is resistant to VOR, FLU, itraconazole (ITRA), anidulafungin (ANDI), and caspofungin (CASPO); and HGV 53.2 is resistant to VOR, FLU, ITRA, ANDI, CASPO, and micafungin. For PDI, the cells (1 × 10⁷ CFU/mL) were incubated with ZnP-hexyl at concentrations of 1.5 and 3.0 μM for 10 min, followed by irradiation with blue LED light for 3 min. The yeasts were subsequently plated on Sabouraud dextrose agar, and colonies were counted after 24 h. PDI mediated by 3 μM ZnP-hexyl eradicated all yeast strains, while at 1.5 μM, it reduced HGV 51 and HGV 53.2 by ~3 log10 and eradicated HGV 23.1. The latter strain was eliminated at the same concentration required for the non–MDR strain (ATCC 90028), suggesting that HGV 51 and HGV 53.2 may exhibit lower susceptibility to PDI under these conditions. Based on these results, ZnP-hexyl-mediated PDI shows potential for combating multidrug-resistant strains of C. albicans, encouraging further investigation.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper